Is the Term ‘Sarcopenia’ Appropriate to Describe Poor Muscle Health in Pediatric Populations?

Vina Phei Sean Tan; David Scott

doi:10.20344/amp.24161

Is the Term ‘Sarcopenia’ Appropriate to Describe Poor Muscle Health in Pediatric Populations?

Authors

Vina Phei Sean Tan Exercise and Sports Science. School of Health Sciences. Universiti Sains Malaysia. Penang. https://orcid.org/0000-0003-0562-734X
David Scott Institute for Physical Activity and Nutrition (IPAN). School of Exercise and Nutrition Sciences. Deakin University. Victoria. https://orcid.org/0000-0001-5226-1972

DOI:

https://doi.org/10.20344/amp.24161

Keywords:

Aging, Child, Muscle Strength, Muscle Weakness, Sarcopenia

Abstract

n/a.

Downloads

Download data is not yet available.

References

Marques M, Baptista F. Pediatric sarcopenia: what do we know? Acta Med Port. 2025;38:800-7 DOI: https://doi.org/10.20344/amp.23301

Rosenberg IH. Sarcopenia: origins and clinical relevance. J Nutr. 1997;127:990S-1S. DOI: https://doi.org/10.1093/jn/127.5.990S

WHO-FIC Foundation. WHO ICD-11. [cited 2025 Oct 27]. Available from: https://icd.who.int/browse/2025-01/foundation/en#216126796.

Kirk B, Cawthon PM, Arai H, Ávila-Funes JA, Barazzoni R, Bhasin S, et al. The conceptual definition of sarcopenia: Delphi consensus from the Global Leadership Initiative in Sarcopenia (GLIS). Age Ageing. 2024;53:afae052.

Correa-de-Araujo R, Hadley E. Skeletal muscle function deficit: a new terminology to embrace the evolving concepts of sarcopenia and age-related muscle dysfunction. J Gerontol A Biol Sci Med Sci. 2014;69:591-4. DOI: https://doi.org/10.1093/gerona/glt208

Dotan R, Mitchell C, Cohen R, Klentrou P, Gabriel D, Falk B. Child - adult differences in muscle activation - a review. Pediatr Exerc Sci. 2012;24:2-21. DOI: https://doi.org/10.1123/pes.24.1.2

Downloads

Published

2026-03-31

How to Cite

Tan VPS, Scott D. Is the Term ‘Sarcopenia’ Appropriate to Describe Poor Muscle Health in Pediatric Populations? . Acta Med Port [Internet]. 2026 Mar. 31 [cited 2026 Jun. 6];39(5):375-6. Available from: https://actamedicaportuguesa.com/revista/index.php/amp/article/view/24161

Download Citation

Issue

Vol. 39 No. 5 (2026): May

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.